Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

NGP1 Inhibitors

NGP1 inhibitors are a class of chemical compounds designed to inhibit the activity of the NGP1 protein, which is involved in various intracellular signaling pathways that regulate cellular growth, differentiation, and stress responses. These inhibitors function by binding to key domains of NGP1, preventing it from interacting with its natural substrates or partners, thereby interfering with the signaling cascade it participates in. Depending on the inhibitor's binding mechanism, it can either block the protein's active site, thereby competitively inhibiting substrate binding, or attach to an allosteric site, inducing a conformational change that affects the protein's function. NGP1 inhibitors are specifically crafted to ensure high selectivity for the NGP1 protein, thereby minimizing off-target effects and unintended interactions with other structurally related proteins. Achieving this selectivity requires detailed knowledge of the structure and active regions of NGP1, which aids in designing compounds that are highly complementary to the target binding sites.

The design and development of NGP1 inhibitors involve multiple advanced methodologies, including structural biology and computational modeling. High-resolution techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, are employed to study the three-dimensional structure of NGP1, providing insight into the key functional domains and potential binding pockets. Computational approaches, such as molecular docking and structure-activity relationship (SAR) analysis, are then used to screen potential inhibitors and predict their interactions with the protein. Chemical optimization, such as the modification of functional groups to enhance binding affinity or stability, is often applied to refine these compounds. NGP1 inhibitors can range from small organic molecules, which fit into the active site, to larger, more complex structures that can interact with multiple domains of the protein. Inhibitor development also requires a careful balance of physicochemical properties, such as solubility, membrane permeability, and stability, to ensure effective interaction with the target protein within a biological environment. Overall, NGP1 inhibitors represent a sophisticated class of molecules developed to precisely modulate the activity of NGP1, providing valuable tools for investigating the role of this protein in cellular signaling pathways.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

This compound binds to DNA at the transcription initiation complex, obstructing elongation and potentially decreasing NGP1 mRNA synthesis by halting the transcription process.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

By intercalating into DNA and inhibiting topoisomerase II, Doxorubicin could cause DNA damage that may result in the downregulation of NGP1 transcription as a cellular response to genotoxic stress.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine can concentrate in the nucleolus and disrupt its function, potentially leading to a decrease in ribosomal RNA synthesis and assembly, which in turn may downregulate NGP1 expression, a protein involved in ribosome biogenesis.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This nucleoside analog can be incorporated into RNA and DNA, where it may inhibit methyltransferase enzymes, leading to hypomethylation of DNA and potentially causing alterations in the chromatin that downregulate NGP1 gene transcription.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Triptolide could inhibit RNA polymerase II activity, leading to a broad decrease in gene transcription, including the reduction of NGP1 mRNA levels.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$270.00
$465.00
$1607.00
$2448.00
$5239.00
4
(1)

By specifically inhibiting the initiation step of protein synthesis, Rocaglamide may prevent the translation of NGP1 mRNA into the protein, effectively reducing NGP1 protein levels.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$68.00
$261.00
8
(1)

Mycophenolic acid inhibits inosine monophosphate dehydrogenase, an enzyme crucial for guanine nucleotide synthesis; this depletion could lead to a decrease in RNA synthesis, including that of NGP1.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

By inhibiting the BET family of bromodomain proteins, JQ1 could alter chromatin accessibility and histone modification states, potentially leading to the specific downregulation of NGP1 gene transcription.

CX-5461

1138549-36-6sc-507275
5 mg
$240.00
(0)

This small molecule selectively inhibits RNA polymerase I-mediated transcription of ribosomal RNA, which could indirectly inhibit NGP1 expression due to disrupted ribosome biogenesis.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

DRB is known to selectively inhibit RNA polymerase II, which would lead to a targeted decrease in mRNA synthesis for many genes, potentially including the NGP1 gene.